Late breast implant infections: a delayed MRSA infection from hematogenous spread in an intravenous drug user

被引：3

作者：

Agochukwu N. ^{[1
]}

Boustany A. ^{[1
]}

Rinker B. ^{[1
]}

机构：

[1] Division of Plastic Surgery, Department of Surgery, University of Kentucky, 740 S. Limestone, Suite K448, Lexington, 40535, KY

来源：

European Journal of Plastic Surgery | 2018年 / 41卷 / 3期

关键词：

Breast implants and intravenous drug abuse; Late breast implant infections; MRSA; Osteomyelitis;

D O I：

10.1007/s00238-017-1362-3

中图分类号：

学科分类号：

摘要：

Infection following breast augmentation is a rare event, with an incidence of 0–4% in most studies. We present the case of a methicillin-resistant Staphylococcus aureus bilateral breast implant infection in a 42-year-old female, 19 years after submuscular saline breast augmentation. Her history was significant for intravenous drug abuse and concomitant osteomyelitis of the sternum and manubrium. She underwent washout and debridement, with explantation of the breast implants, and long-term intravenous vancomycin. This represents the longest reported occurrence of late infection in breast augmentation and the only report of a breast implant infection due to hematogenous spread/seeding from intravenous drug abuse. Level of Evidence: Level V, risk study. © 2017, Springer-Verlag GmbH Germany.

引用

页码：351 / 354

页数：3

共 29 条

[1]

ASPS National Clearinghouse of Plastic Surgery, (2016)

[2]

Araco A., Gravante G., Araco F., Delogu D., Cervelli V., Walgenbach K., Infections of breast implants in aesthetic breast augmentations: a single-center review of 3,002 patients, Aesthetic Plast Surg, 31, pp. 325-329, (2007)

[3]

Basile A.R., Basile F., Basile A.V., Late infection following breast augmentation with textured silicone gel-filled implants, Aesthet Surg J, 25, pp. 249-254, (2005)

[4]

Benito-Ruiz J., Nipple shields in transaxillary breast augmentation, Ann Plast Surg, 78, pp. 397-402, (2017)

[5]

Codner M.A., Mejia J.D., Locke M.B., Mahoney A., Thiels C., Nahai F.R., Hester T.R., Nahai F., A 15-year experience with primary breast augmentation, Plast Reconstr Surg, 127, pp. 1300-1310, (2011)

[6]

Hvilsom G.B., Holmich L.R., Henriksen T.F., Lipworth L., McLaughlin J.K., Friis S., Local complications after cosmetic breast augmentation: results from the Danish Registry for Plastic Surgery of the breast, Plast Reconstr Surg, 124, pp. 919-925, (2009)

[7]

Khan U.D., Breast augmentation, antibiotic prophylaxis, and infection: comparative analysis of 1,628 primary augmentation mammoplasties assessing the role and efficacy of antibiotics prophylaxis duration, Aesthetic Plast Surg, 34, pp. 42-47, (2010)

[8]

Rubino C., Brongo S., Pagliara D., Infections in breast implants: a review with a focus on developing countries, J Infect Dev Ctries, 8, pp. 1089-1095, (2014)

[9]

Cohen J.B., Carroll C., Tenenbaum M.M., Myckatyn T.M., Breast implant-associated infections: the role of the National Surgical Quality Improvement Program and the local microbiome, Plast Reconstr Surg, 136, pp. 921-929, (2015)

[10]

Macadam S.A., Mehling B.M., Fanning A., Nontuberculous mycobacterial breast implant infections, Plast Reconstr Surg, 119, pp. 337-344, (2007)

← 1 2 3 →